RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharmagreen Biotech Stock

Pharmagreen Biotech P/S 2025

Pharmagreen Biotech P/S

290.9

Ticker

PHBI

ISIN

US71716C1099

WKN

A2NB5X

As of Jul 3, 2025, Pharmagreen Biotech's P/S ratio stood at 290.9, a 211.76% change from the 93.31 P/S ratio recorded in the previous year.

The Pharmagreen Biotech P/S history

Pharmagreen Biotech Aktienanalyse

What does Pharmagreen Biotech do?

Pharmagreen Biotech Inc is a Canadian company specializing in the production of cannabis plants. The company was founded in 2009. Initially, the company focused primarily on research in the field of plant biotechnology. It worked on developing plants with higher cold resistance for cultivation in colder regions. Research in breeding plants with higher nutritional value was also part of their focus. In 2017, the company recognized the incredible potential of the cannabis industry and decided to apply its expertise in this field. Pharmagreen Biotech Inc began large-scale production of cannabis plants, working closely with other industry leaders to optimize production and create the best possible conditions. Pharmagreen Biotech Inc places great importance on sustainability and environmental awareness. All production methods are designed with ecological sustainability in mind. The plants are grown in environmentally-friendly greenhouses and all waste is recycled and reused. The business model of Pharmagreen Biotech Inc is tailored to the needs of its customers. The company produces cannabis plants for the medical and recreational sectors. It offers various types of plants to meet the needs of customers, including plants for home cultivation to cater to the growing market for self-grown cannabis plants. Products offered by Pharmagreen Biotech Inc also include seeds, fertilizers, and specialized cultivation kits tailored to the needs of cannabis plants. The company works closely with laboratories and research institutions to maximize and optimize the quality and potency of its products. The company recently developed a new technology called "Speed Breeding," which allows for the rapid breeding of cannabis plants. This enables Pharmagreen Biotech Inc to serve an even larger portion of the market and provide faster availability of products for customers. Pharmagreen Biotech Inc is divided into various divisions, including medical cannabis production, recreational cannabis, plant products, and seed production. Each division is led by a specialized team focused on the needs and requirements of customers in that area. Overall, Pharmagreen Biotech Inc is an innovative and sustainable company focused on the needs of its customers. Its wide range of products and ongoing research and development make it an important player in the rapidly growing cannabis industry. Pharmagreen Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Pharmagreen Biotech's P/S Ratio

Pharmagreen Biotech's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Pharmagreen Biotech's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Pharmagreen Biotech's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Pharmagreen Biotech’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Pharmagreen Biotech stock

What is the price-to-earnings ratio of Pharmagreen Biotech?

The price-earnings ratio of Pharmagreen Biotech is currently 290.9.

How has the price-earnings ratio of Pharmagreen Biotech changed compared to last year?

The price-to-earnings ratio of Pharmagreen Biotech has increased by 211.76% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Pharmagreen Biotech high compared to other companies?

Yes, the price-to-earnings ratio of Pharmagreen Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of Pharmagreen Biotech affect the company?

An increase in the price-earnings ratio of Pharmagreen Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Pharmagreen Biotech affect the company?

A decrease in the price-earnings ratio of Pharmagreen Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Pharmagreen Biotech?

Some factors that influence the price-earnings ratio of Pharmagreen Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Pharmagreen Biotech pay?

Over the past 12 months, Pharmagreen Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmagreen Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Pharmagreen Biotech?

The current dividend yield of Pharmagreen Biotech is .

When does Pharmagreen Biotech pay dividends?

Pharmagreen Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmagreen Biotech?

Pharmagreen Biotech paid dividends every year for the past 0 years.

What is the dividend of Pharmagreen Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmagreen Biotech located?

Pharmagreen Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmagreen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmagreen Biotech from 7/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2025.

When did Pharmagreen Biotech pay the last dividend?

The last dividend was paid out on 7/3/2025.

What was the dividend of Pharmagreen Biotech in the year 2024?

In the year 2024, Pharmagreen Biotech distributed 0 USD as dividends.

In which currency does Pharmagreen Biotech pay out the dividend?

The dividends of Pharmagreen Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmagreen Biotech

Our stock analysis for Pharmagreen Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmagreen Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.